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1. Introduction 
Two major topics were covered in this chapter. The first was to explore a method of 
establishing a rabbit model of SVCS by injecting VX2 tumor cell suspension 
transcutaneously under ultrasound guidance, and to observe the radiotherapeutic effects by 
SVC Doppler flow changes. The establishment of this model would offer an experimental 
evidence for better diagnosis, treatment and follow-up observation of SVCS. The second was 
to investigate the evolution of the SVC Doppler flow changes in patients with SVCS and its 
value in assessing clinical therapeutic effects in these patients.  
An animal SVC obstruction model would be of use in further studies directed at optimizing 
the therapeutic strategies for original tumors causing SVC syndrome in patients, yet no 
detailed information about the establishment of an animal SVC obstruction (SVCO) model 
can be found in the literature. It has been reported that VX2 tumor cell could be successfully 
inoculated into multiple organs to induce malignant tumors in rabbits (De Crespigny et al, 
1999; Goldberg et al, 1999; Ishida et al, 2000), and various imaging modalities has been 
adopted to assess the effect of this inoculation (Kim et al, 2000; Liu et al, 2001). We 
hypothesize that a rabbit model with SVCO could be established by inoculating VX2 tumors 
cells into the areas around the SVC.  
Superior vena cava syndrome (SVCS) is a clinical expression of obstruction of blood flow 
through the SVC, and more than 80% cases are caused by malignant tumors. Though 
contrast-enhanced spiral or multi-slice CT is now able to identify accurately the site of 
occlusion or stenosis, it has been greatly limited by its high cost and radiation and thus is 
not appropriate for follow-up observations. In contrast, ultrasound is safe, reproducible, and 
relatively inexpensive. Doppler ultrasonography has been successfully used to assess the 
rabbit SVC obstruction model. We hypothesize that Doppler flow patterns of SVC could be 
applied for assessing the severity of SVCS and its therapeutic effects. 
2. Objective 
There are three objectives for the animal study. The first is to study the feasibility of 
establishing a model of SVCO in rabbits by infusing VX2 tumor cell suspension 
transcutaneously with ultrasound guidance, and to evaluate the applications of this animal 
model. The second is to study morphologic and hemodynamic changes of superior vena 
cava (SVC) in rabbits with SVCO using two-dimensional and Doppler ultrasound and to 
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explore the relationship between the tumor size in specimen and the two-dimensional and 
Doppler ultrasonographic characteristics. The third is to analyze the ultrasonographic 
characteristics and histopathological changes after radiotherapy in rabbits with SVCO, and 
to provide useful information for assessing the SVC syndrome therapeutic effect in clinic.   
The objective of the human study was to evaluate the Doppler SVC’s flow patterns and their 
value in assessing SVCS. 
3. Materials and methods 
3.1 Animals model establishment 
Fifteen adult healthy New Zealand White rabbits were enrolled in this study. Anesthesia 
was performed by injecting Ketamine Hydrochloride into the posterior leg muscles of 
rabbits at a dose of 30mg/ kg. The VX2 tumor cell suspension was prepared under the sterile 
condition. About 0.1ml tumor cell suspension was infused transcutaneously in front of SVC 
and close to its anterior wall guided by ultrasound. The SVC morphology and 
hemodynamics as well as the tissues around SVC were examined with two-dimensional and 
Doppler ultrasonography once every 3 days from the 9th day after the injection of tumor cell 
suspension till the natural death of the rabbits. These findings were compared with those by 
CT and digital subtraction angiography (DSA).  
3.2 Ultrasonographic examinations 
One rabbit did not develop tumor after the injection of VX2 tumor cell suspension and thus 
excluded. The rest of the fourteen rabbit models of SVCO were examined by two-
dimensional and Doppler ultrasonography using Sequoia 512 computed ultrasonograph 
with the probe of 7v3c.  
The sizes of the tumor and the SVC morphology and hemodynamics were observed with 
the transducer placed in the right supraclavicular region view using Sequoia 512 computed 
ultrasonograph once every 3 days from the 12th day after the injection, and compared with 
the ultrasonographic findings before injection. The ultrasonographic findings were also 
compared with those of CT and autopsy findings, respectively. 
3.3 Radiotherapy for rabbits with SVCO due to VX2 tumor injection 
Thirteen survived rabbits with SVCO due to VX2 tumor were enrolled in this study. The 
tumors in mediastina were exposed one minute with 2gy everyday by SIEMNS 
MEVATRON 6745, which was 10 times in all. Before the radiotherapy and On the 10, 17 and 
24 day after radiotherapy, the sizes of the tumor and SVC, SVC velocities and echo 
characteristics in the 13 rabbits were detected with the transducer placed in the right 
supraclavicular region using Sequoia 512 computed ultrasonograph. The mediastina 
neoplasm tissue before and after radiotherapy were sampled for HE staining and TUNEL 
for analysis of the number of the apoptotic cells. 
3.4 Patients 
Forty-two patients (26 females and 16 males) with SVCS caused by neoplasm (34 with right 
upper lung cancer and 8 with mediastinal tumor), aged from 22 to 56 years old were 
included in this study when they were scheduled for radiotherapy and/ or chemotherapy 
treatment from January 2000 to June 2005. All the patients had upper extremity and facial 
swelling at initial diagnosis. Twenty volunteers (15 males and 5 females) aged 23–52 years 
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with no history of cardiac and pulmonary diseases were recruited as controls. All informed 
consents of the patients were acquired. 
3.5 Methods of human study 
Acuson Sequoia 512 ultrasonograph equipped with7V3C transducer was used. 
Electrocardiogram and respiratory curve were recorded simultaneously. The following 
procedures were in accordance with the ethical standards of the committee on human 
experimentation of the institution and approved by Tangdu Hospital committee.  
Right supraclavicular approach. Patients took a supine position. With the transducer placed in 
the fossa between the sterna and clavicular heads of the sternomastoid muscle, the upper 
part of the SVC and its adjacent structures were fully displayed.  
Subcostal approach. Patients took a supine position. With the transducer placed in the 
subcostal region, the lower part of SVC was displayed.  
The SVC spectra were recorded. The flow velocities of the two forward waves, systolic wave 
(S) and diastolic wave (D) and the two reversed waves during ventricular and atrial 
contraction (VR and AR), were measured. The variation of these flow velocities with cardiac 
cycle and respiration was analyzed with SPSS software. All the patients were followed up 
for more than 11 months. 
4. Results 
4.1 The success rate of establishing SVCO rabbit models 
Fourteen rabbits were found to have the tumors para-SVC and/ or in the SVC cavity by 
ultrasonography. One rabbit dropped off because no tumor grew until 42nd day after the 
infusion. The success rate of developing rabbit SVCO model was about 93.33%.  
4.2 Two-dimensional ultrasonographic findings of SVCO 
The diameters of the tumors were (80.70±4.28) mm. With the tumor growing, the lumen of 
SVC was deformed and narrowed, and the wall of SVC was disrupted shown by two-
dimensional ultrasonography (Figure 1 and 2). The tumor size growth was linearly 
correlated with time, and the correlation coefficient was 0.9855 (Figure 3). The tumor 
diameter by ultrasound was similar to the diameter by autopsy ((80.70±4.28mm vs. 
82.16±3.41mm, t=0.998, P=0.327405).  
 
 
Fig. 1. Two-dimensional ultrasonography of normal SVC 
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Fig. 2. Two-dimensional ultrasonography of a rabbit with SVCO 
 
 
Fig. 3. Tumor growing with time  
4.3 SVCO development 
All the 14 rabbits developed SVCO. In eight rabbits, SVC was found to be oppressed by two-
dimensional ultrasonography on the 15th day after infusion, Aliasing mosaic flow signals 
and high flow velocity spectra in SVC were demonstrated by Doppler ultrasonography. In 
another 4 rabbits, the stenotic blood flow velocities were displayed on the 18th day after 
infusion. In the last 2 rabbits, the abnormal blood flow was seen on the 21st and the 24th 
day, respectively.  
4.4 The different stages of SVCO 
The development of SVCO could be divided into three stages. Early stage: About 1 week 
after. The tumor area was 0.5 cm2~3cm2. The echotexture was hpyoechoic and evenly 
distributed, the shape of the tumor was regular with pseudocapsule. SVC was compressed, 
but the SVC wall was relatively intact (Figure 4). Mid stage: the tumor area was 3.1 cm2~6.0 
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cm2. Most of the tumors still were hypoechoic echotexture. Hyperechoic textures could be 
seen within some tumors. T shape of the tumor was not regular. At this stage, the SVC was 
oppressed and its course became abnormal; the lumen of SVC was narrowed, and the wall 
was infiltrated by tumors (Figure 5). Late stage: The tumor area reached more than 6.1 cm2, 
and the shape was dramatically irregular. Mixing echotexture was seen, but was mainly 
hypoechoic. SVC was severely oppressed and correlated well with the size of the tumor 
(Figure 6). The ultrasonographic findings of SVCO at the late stage correlated well with 
those findings by CT and the autopsy.  
 
 
Fig. 4. SVC being compressed by a mass (M) in a rabbit with SVCO. The wall of SVC is intact 
 
 
Fig. 5. SVC being compressed in a rabbit with SVCO. The wall of SVC is infiltrated by the 
mass (M) 
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Fig. 6. Relationship between the tumor size and the SVC diameter 
4.5 Doppler ultrasonographic findings of SVCO 
In SVCO, the color Doppler ultrasound showed mosaic or weak or even no flow signals 
within SVC (Figure 7). In normal rabbits, the pulsed Doppler ultrasound showed laminar 
flow in SVC (Figure 8); while in rabbits with SVCO, the SVC flow was turbulent and the 
spectral window was disappeared (Figure 9). The peak flow velocities of SVC waves were 
less influenced by respiratory cycle in SVCO compared to normal (Figure 10). SVC flow 
velocities significantly increased during early and mid stages of SVCO (Table 1).  
 
 S D VR AR 
Early and middle stages 78.25±14.97 59.68±13.16 19.22±4.99 17.44±2.67 
Late stage 33.71±18.90 33.55±20.03 10.53±3.27 9.33±1.58 
T 6.912 4.079 5.450 9.781 
P ＜0.0001 0.0004 ＜0.0001 ＜0.0001 
Table 1. SVC flow velocities changes at different stages of SVCO（ x ± s, cm/ s） 
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Fig. 7. Mosaic and thread-like color Doppler flow signals were seen in SVC in a rabbit with 
SVCO by color Doppler ultrasonography. T: tumor 
 
 
Fig. 8. Normal SVC Doppler flow  
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Fig. 9. Increased SVC Flow velocities in the same rabbit as shown in figure 7 
 
 
Fig. 10. Peak velocities of SVC waves were less influenced by respiratory cycle than normal 
4.6 Evaluation of radiotherapeutic effect in SVCO rabbits  
The tumor showed a tendency to get smaller after radiotherapy. The echotexture of the 
tumor partly turned to be hyperechoic. The diameter of SVC become bigger and the flow 
velocities decreased at the site of tumor compared with that before the radiotherapy (Figure 
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11 and 12). The tumor diameter, SVC diameter and velocity changes after radiotherapy were 
shown in table 2.  
 
 
Fig. 11. SVC Doppler flow waveforms before the radiotherapy 
 
 
Fig. 12. SVC Doppler flow velocities decreased after radiotherapy from the same patient 
shown in figure 11 
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 D1 (mm) D2(mm) SysVmax（cm/ s） 
Before radiotherapy 17.86±1.12 2.65±0.32 87.38±12.94 
10d after radiotherapy 17.64±1.08 2.78±0.37 84.65±11.46 
17d after radiotherapy 17.13±1.18 2.94±0.93 81.37±11.50 
24d after radiotherapy 16.38±1.60 3.23±0.28 77.55±12.34 
Table 2. Tumor diameter (D1), SVC diameter (D2) and systolic maximal flow velocity 
(SysVmax) changes after radiotherapy  
HE staining and TUNEL assay showed that the number of apoptotic cells in the tumor was 
much more than that before the radiotherapy (Figure 13& 14) (P<0.01). 
 
 
Fig. 13. HE staining showing that the apoptotic cells increased after radiotherapy (Right) 
compared to those before (Left) 
 
 
Fig. 14. TUNEL assay showing that the apoptotic cells increased after radiotherapy (Right) 
compared to those before (Left) 
4.7 SVC Doppler flow in patients with SVCS  
Different from healthy subjects, where laminar flow was demonstrated (Figure 15), the SVC 
flow spectra in patients with mild SVCS showed turbulent flow (Figure 16) and the spectral 
window was disappeared. In patients with moderate degree of SVCS, the distinct biphasic 
forward waves (S- and D-waves) of SVC were lost (Figure 17). In addition, we found that 
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the smaller of the VR- and AR-waves were, the farther the oppressed segment of SVC was 
away from the right atrium. 
 
 
Fig. 15. SVC Doppler flow spectra in healthy subjects. Doppler interrogation of the SVC 
shows systolic and diastolic phases of flow (S- and D-waves) toward the heart and late 
ventricular systolic and atrial systolic phases of backward flow (VR- and AR-waves) 
 
 
Fig. 16. SVC Doppler flow spectra in mild SVCS. The forward waves showed high velocity 
and no distinct spectral window 
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Fig. 17. SVC Doppler flow spectra in severe SVCS. The S, D AR, and VR waves could not be 
identified 
The RVI in SVCS group were much lower than those in the control group (S-wave: 1.9±3.6 % 
vs.16.34±8.96%, P = 0.0003; D-wave: 2.80±1.23% vs. 26.32±42%, P =0.0087). After treatment, 
the flow velocities of SVC decreased significantly with each month and the RVI was 
significantly increased compared to those before the treatment.  
5. Comments 
The animal study demonstrated that SVCO rabbit model could be easily established 
transcutaneously with the guidance of ultrasound. With VX2 tumor growing, SVC was 
oppressed and/ or infiltrated by the tumor tissues and ultimately resulted in the blockage of 
the SVC, and developed SVCO. The pathogenesis of SVCO in rabbits was similar to that of 
SVCO in humans, indicating that this rabbit model of SVCO caused by VX2 tumor could be 
an ideal model of SVCO.   
Two-dimensional ultrasonography could be used to demonstrate the morphologic changes 
of the tumor and SVC. Color Doppler could sensitively detect the abnormal blood flow of 
SVC in rabbits with SVCO. It could be mosaic, weak or even no flow signals depending on 
the different stages and severity of SVCO. Doppler flow spectra of SVC showed less 
respiratory influences on the flow velocities in rabbits with SVCO.  
Linear accelerator radiotherapy could lead to cell apoptosis of the VX2 tumor transplanted 
besides SVC. HE staining and TUNEL assay showed increased number of apoptotic cells of 
the tumor tissue compared to that before radiotherapy. With the apoptosis of the tumor 
cells, the echotexture of the tumor partly turned to be hyperechoic and the tumor itself was 
getting smaller. Thereby the oppression severity of the SVC was decreased, the diameter of 
SVC was getting bigger, and finally the obstruction was getting resolved. 
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With the release of the obstruction after radiotherapy, the respiratory variation of the SVC 
Doppler flow velocities could be recovered and the peak flow velocities of SVC decreased 
gradually after the treatment shown by Doppler ultrasonography. However, the tumor size, 
SVC diameter and the flow velocity could not completely get back to normal after treatment. 
This suggests that Linear accelerator radiotherapy could not inactivate VX2 tumor 
completely, which might be related to the high grade of malignancy, poor proliferation of 
the VX2 tumors. 
The human study demonstrates that respiratory variations of SVC Doppler flow velocities 
are significantly decreased in patients with SVCS, but could be recovered gradually after 
treatment, indicating that respiratory variations of Doppler flow changes of SVC correlate 
well with the severity of SVCS, and may be used to assess the therapeutic effects of SVCS.  
The SVC Doppler flow patterns in patients with SVCS were characterized with fill-in and 
broaden spectra, nondistinct outlines. The D-wave was unable to return to the baseline at 
end diastole, which was consistent with previous studies (Yano&Shimada, 1997). When the 
patients’ condition improved after treatment, , the pressure gradient at the stenotic segment 
of SVC also decreased, indicating that SVC hemodynamic changes was in accordance with 
the clinical courses of SVCS (Behar et al., 2001; Tighe et al., 2000).   
It has been well known that, respiration had significant influence on SVC flow velocities in 
healthy subjects. The S- and D-wave peak velocities are much greater on inspiration 
compared with those on expiration because the decreased intrathoracic pressures during 
inspiration causes increased venous return (Jellinek et al., 2000; Vieillard et al., 2001). In 
patients with SVCS, However, the obstruction prevents the conduction of the intrathoracic 
pressure changes into the right atrium and to SVC, resulting in decreased or even 
diminished respiratory variations of S- and D-wave flow velocities. Once this obstruction is 
released after treatment, the SVC Doppler flow velocities would decrease and the 
respiratory variations of these flow velocities would be back. 
6. Conclusions 
Rabbit model of SVCO caused by VX2 tumor could be an ideal model of SVCO for clinical 
study. Doppler ultrasound is the first method of choice for assessing the hemodynamics of 
SVCO.  
Normally, respiration had significant influence on SVC morphology and dynamics in 
healthy subjects. This influence would become less in the patients with SVCS, suggesting 
that SVC Doppler spectra could reflect the severity of SVCS. 
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